Table 1.
Numbers and distribution of ER visits between 2019 and 2020 and relevant changes.
| 2020n (% of visits in the time period) | 2019n (% of visits in the time period) | Absolute reduction (percent) | |
| Total visits | 653 | 1133 | −42.3% |
| Visits requiring further hospitalization | 217 | 333 | −34.8% |
| Infections (all sites) | 202 (30.9%) | 208 (18.4%) | −2.8% |
| Upper respiratory tract infections | 93 (14.2%) | 77 (6.8%) | +20.7% |
| Lower respiratory tract infection | 33 (5%) | 25 (2.2%) | +32% |
| Other site or non-specified site of infection | 76 (11.6%) | 106 (9.3%) | −28.3% |
| Non-specific GI complaints (nausea, vomiting, abdominal pain) | 102 (15.6%) | 248 (21.9%) | −58.8% |
| Non-specific general complaints (fatigues, back or other non-specific pain, etc) | 24 (3.7%) | 80 (7.1%) | −70% |
| Cancer complication management | 34 (5.2%) | 58 (5.1%) | −41.4% |
| Symptoms of cardiac origin (angina, non-specific chest pain) | 59 (9%) | 93 (8.2%) | −36.6% |
| Acute coronary syndrome | 14 (2.1%) | 20 (1.7%) | −30% |
| Stroke | 6 (0.9%) | 18 (1.5%) | −67% |
| Cardiovascular disease∗ (all pooled) | 79 (12.1% | 131 (11.6%) | −39.7% |
| Arrhythmia/palpitations | 37 (5.6%) | 48 (4.2%) | −23% |
| Heart failure/decompensation | 24 (3.7%) | 35 (3.1%) | −31.4% |
| Syncope/pre-syncope | 13 (2%) | 21 (1.9%) | −38% |
| Uncontrolled hypertension/hypertensive spike | 14 (2.1%) | 40 (3.5%) | −65% |
| GI bleeding (suspected or confirmed) | 24 (3.7%) | 53 (4.7%) | −54.7% |
| “Colitis” of any cause | 1 (0.15%) | 6 (0.5%) | −83% |